Escherichia fergusonii bacteremia in a diabetic patient with pancreatic cancer
Journal
Journal of Clinical Microbiology
Journal Volume
49
Journal Issue
11
Pages
4001-4002
Date Issued
2011
Author(s)
Abstract
Although Escherichia fergusonii has been identified for decades, it has rarely been recovered from clinical specimens and its clinical significance remains unclear. We describe a case of E. fergusonii bacteremia in a diabetic patient with pancreatic cancer. The isolate was confirmed by three commercial identification systems and 16S rRNA gene sequence analysis. The patient's clinical condition gradually improved, and repeated blood cultures were negative after antibiotic treatment with an in vitro active agent (ceftriaxone). Copyright ? 2011, American Society for Microbiology. All Rights Reserved.
SDGs
Other Subjects
amikacin; amoxicillin plus clavulanic acid; ampicillin; antibiotic agent; cefepime; ceftriaxone; cefuroxime; ciprofloxacin; gentamicin; imipenem; piperacillin plus tazobactam; RNA 16S; aged; antibiotic therapy; article; bacteremia; bacterium isolate; blood culture; case report; computer assisted tomography; diabetic patient; Escherichia; Escherichia coli infection; Escherichia fergusonii; gene sequence; human; in vitro study; Klebsiella pneumoniae; laboratory test; male; nonhuman; nucleotide sequence; pancreas cancer; physical examination; priority journal; Aged; Anti-Bacterial Agents; Bacteremia; Diabetes Complications; DNA, Bacterial; DNA, Ribosomal; Enterobacteriaceae Infections; Escherichia; Humans; Male; Pancreatic Neoplasms; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Treatment Outcome; Escherichia fergusonii
Type
journal article